Ginsenoside Re (CAS 52286-59-6)
QUICK LINKS
Ginsenoside Re is a compound researched for its role in biological systems, particularly in the study of cellular metabolism and stress response. In plant science research, it is investigated for its contribution to the resilience of Panax ginseng against environmental stresses. Researchers also explore Ginsenoside Re in the context of biochemistry, examining its interaction with cell membrane components and potential signaling pathways. Studies often focus on its effects on cellular energy regulation, as Ginsenoside Re has been observed to influence ATP production in mitochondria. Additionally, its impact on the modulation of gene expression is a subject of genetic research, where scientists aim to understand the underlying mechanisms by which Ginsenoside Re can affect cellular functions.
Ginsenoside Re (CAS 52286-59-6) References
- Ginsenoside Re: pharmacological effects on cardiovascular system. | Peng, L., et al. 2012. Cardiovasc Ther. 30: e183-8. PMID: 21884006
- Ginsenoside Re Attenuates Isoproterenol-Induced Myocardial Injury in Rats. | Wang, QW., et al. 2018. Evid Based Complement Alternat Med. 2018: 8637134. PMID: 29849732
- Ginsenoside Re inhibits PDGF-BB-induced VSMC proliferation via the eNOS/NO/cGMP pathway. | Gao, Y., et al. 2019. Biomed Pharmacother. 115: 108934. PMID: 31082773
- Ginsenoside Re enhances the survival of H9c2 cardiac muscle cells through regulation of autophagy. | Zhang, ZL., et al. 2020. J Asian Nat Prod Res. 22: 774-787. PMID: 31232107
- Ginsenoside Re Mitigates 6-Hydroxydopamine-Induced Oxidative Stress through Upregulation of GPX4. | Lee, GH., et al. 2020. Molecules. 25: PMID: 31906464
- Ginsenoside Re Attenuates High Glucose-Induced RF/6A Injury via Regulating PI3K/AKT Inhibited HIF-1α/VEGF Signaling Pathway. | Xie, W., et al. 2020. Front Pharmacol. 11: 695. PMID: 32528282
- Ginsenoside Re Treatment Attenuates Myocardial Hypoxia/Reoxygenation Injury by Inhibiting HIF-1α Ubiquitination. | Sun, H., et al. 2020. Front Pharmacol. 11: 532041. PMID: 33013381
- Ginsenoside Re exhibits neuroprotective effects by inhibiting neuroinflammation via CAMK/MAPK/NF‑κB signaling in microglia. | Madhi, I., et al. 2021. Mol Med Rep. 24: PMID: 34368872
- UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats. | Wang, H., et al. 2021. Molecules. 26: PMID: 34771066
- Pharmacological Properties of Ginsenoside Re. | Gao, XY., et al. 2022. Front Pharmacol. 13: 754191. PMID: 35462899
- A comprehensive system review of pharmacological effects and relative mechanisms of Ginsenoside Re: Recent advances and future perspectives. | Cai, J., et al. 2022. Phytomedicine. 102: 154119. PMID: 35617888
- Ginsenoside Re attenuates myocardial ischemia/reperfusion induced ferroptosis via miR-144-3p/SLC7A11. | Ye, J., et al. 2023. Phytomedicine. 113: 154681. PMID: 36893674
- Ginsenoside Re inhibits myocardial fibrosis by regulating miR-489/myd88/NF-κB pathway. | Sun, J., et al. 2023. J Ginseng Res. 47: 218-227. PMID: 36926602
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Ginsenoside Re, 1 mg | sc-205707 | 1 mg | $57.00 | |||
Ginsenoside Re, 5 mg | sc-205707A | 5 mg | $111.00 |